Trial Details

RECRUITING
Basic Information
Clinical ID c1001
Identifier NCT04624230
Trial Title Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: tofacitinib
Participant Information
Sponsor Pfizer
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2021-08-12
Primary Completion Date 2027-02-23
Completion Date 2029-05-15